fbpx
QQQ
+ 3.65
315.78
+ 1.14%
DIA
+ 4.30
299.09
+ 1.42%
SPY
+ 4.76
369.89
+ 1.27%
TLT
-0.60
154.37
-0.39%
GLD
+ 2.03
170.55
+ 1.18%

1 in 4 CBD Edibles Have Inaccurate Labels, Study Shows

November 12, 2020 2:44 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
1 in 4 CBD Edibles Have Inaccurate Labels, Study Shows

Only 25% of CBD edibles contain the labeled amount of CBD.

That's according to the results retrieved from a study conducted by Leafreport and its partner lab, Canalysis.

Moreover, potency tests revealed that 63% of products had more CBD than labeled.

Lital Shafir, Leafreport's head of products, said Thursday that "some discrepancies were expected," considering that "edibles are harder to measure compared to tinctures, capsules, and other products."

However, he emphasized that the "degree of discrepancy shows yet again the importance of researching the brand before buying and checking the third-party lab results for the products they are most interested in."

According to experts' recommendations, cannabinoid levels in cannabis products shouldn't deviate more than 10%, compared to the amount that's advertised. In addition, CBD products should have between 90% to 110% of the claimed CBD amount.

The Israel-based Leafreport tested over 40 edible products, with only ten that had CBD levels within 10% of the advertised amount. The majority of the companies producing CBD products that satisfied the conditions were "newer, smaller brands."

Meantime, mislabeling seems to be a trend, as other categories of cannabis products, including infused beverages, showed some discrepancies as well.

In September, Leafreport disclosed it had tested 22 infused beverages from 20 popular brands, revealing that 54% of the products contained less CBD than claimed.

Related Links

Are CBD Labels Accurate? Too Many Brands Are Misleading Consumers, Studies Show

4 Takeaways From The FDA's CBD Accuracy Report


Related Articles

Gage Cannabis Completes $50M Financing Round, Plans To Go Public Via M&A

Gage Growth Corp. closed a $50 million financing round. The Detroit-based cannabis company issued 28.57 million subordinate voting shares for the offering, and added more than 1,000 shareholders, including both institutions and investors. read more

Ayr Strategies Expands In Arizona, Acquires Blue Camo For More Than $75M

Ayr Strategies Inc. (CSE: AYR.A) (OTCQX: AYRWF) confirmed Wednesday a $75.4 million worth acquisition of Blue Camo LLC. read more

Cannabis Trade Organization Taps Beverage Industry Veterans To Join New Council

The American Trade Association for Cannabis and Hemp (ATACH) confirmed Wednesday it will create a Cannabis Beverage Council. The association further noted that the council will include eminent cannabis industry veterans who are concentrate on the cannabis beverage sector. read more

Sol Flower To Launch Recreational Cannabis Sales In Arizona

Sol Flower is kicking off recreational cannabis sales in Arizona on Thursday, Jan. 28. The Phoenix-based dispensary brand received approval from the Arizona Department of Health Services to operate a recreational facility last week. Sol Flower will continue to serve medical marijuana patients as well. read more